Cardinal Health Stock: Analyst Estimates & Ratings

Core Insights - Cardinal Health, Inc. has significantly outperformed the broader market in 2025 and over the past year, with stock prices increasing by 66.4% in 2025 and 73.9% over the past 52 weeks, compared to the S&P 500 Index's gains of 15.6% year-to-date and 17.5% over the past year [2][4] Company Performance - The company reported a robust Q1 performance on October 30, with a year-over-year revenue increase of 22.4% to $64 billion, surpassing expectations by 8.4% [4] - Adjusted EPS for the quarter surged 35.6% year-over-year to $2.55, exceeding consensus estimates by 15.4% [4] - For the full fiscal 2026, analysts project an adjusted EPS of $9.92, reflecting a 20.4% year-over-year increase [5] Analyst Ratings - Among 15 analysts covering Cardinal Health, the consensus rating is a "Strong Buy," consisting of 11 "Strong Buys" and four "Holds" [5] - Wells Fargo analyst Stephen Baxter maintained an "Overweight" rating on Cardinal Health and raised the price target from $185 to $221, indicating a potential upside from current levels [6]